Cognitive Disorders Clinical Trial
Official title:
Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders
Alzheimer's disease is the leading cause of dementia in people over 60 years of age. It is
characterized by a decline in memory, learning ability and other cognitive domains (language,
gnosis, praxis, attention), with a gradual progression of cognitive and behavioral symptoms.
Because of the difficulties it causes in carrying out daily living activities, it has a very
significant impact on the autonomy of patients suffering from it.
To date, there are various non-drug strategies available to manage these difficulties. Thus,
in recent years, more and more studies have shown the benefits that can be gained by several
patients care including physical activity, on cognitive function and general quality of life
of the elderly people without cognitive impairment but also for patients suffering from
Alzheimer's disease or a related pathology.
The objective of this study is to evaluate the effectiveness of adapted physical activity on
self-esteem and motivation in patients with neurocognitive disorders. Stimulation groups are
proposed within the Claude Pompidou Institute. Within these groups we offer an adapted
physical activity program that we have developed in our department. More specifically, it is
a study that aims to evaluate the impact of physical activity on the self-esteem and
motivation of patients who perform these exercises for 12 weeks, at the rate of one hour per
week.
The interest of this study lies in the validation of the effectiveness of such patient care,
which would make it possible to promote its dissemination and strengthen the accessibility of
this type of non-drug management to elderly people suffering from neurocognitive disorders.
Alzheimer's disease is the leading cause of dementia in people over 60 years of age. It is
characterized by a decline in memory, learning ability and other cognitive domains (language,
gnosis, praxis, attention), with a gradual progression of cognitive and behavioral symptoms.
Because of the difficulties it causes in carrying out daily living activities, it has a very
significant impact on the autonomy of patients suffering from it.
To date, there are various non-drug strategies available to manage these difficulties. Thus,
in recent years, more and more studies have shown the benefits that can be gained by several
patients care including physical activity, on cognitive function and general quality of life
of the elderly people without cognitive impairment but also for patients suffering from
Alzheimer's disease or a related pathology.
The objective of this study is to evaluate the effectiveness of adapted physical activity on
self-esteem and motivation in patients with neurocognitive disorders. Stimulation groups are
proposed within the Claude Pompidou Institute. Within these groups we offer an adapted
physical activity program that we have developed in our department. More specifically, it is
a study that aims to evaluate the impact of physical activity on the self-esteem and
motivation of patients who perform these exercises for 12 weeks, at the rate of one hour per
week.
The interest of this study lies in the validation of the effectiveness of such patient care,
which would make it possible to promote its dissemination and strengthen the accessibility of
this type of non-drug management to elderly people suffering from neurocognitive disorders.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
| Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
| Completed |
NCT02342041 -
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT01659593 -
Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT01561820 -
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
|
N/A | |
| Completed |
NCT00743405 -
Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT05373394 -
Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
|
||
| Completed |
NCT04860414 -
Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.
|
N/A | |
| Completed |
NCT02324153 -
Ramelteon in the Prevention of Post-operative Delirium
|
Phase 2 | |
| Completed |
NCT00458094 -
Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses
|
N/A | |
| Completed |
NCT05486195 -
A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect
|
Phase 1 | |
| Recruiting |
NCT02876536 -
Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT02321475 -
EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
|
||
| Completed |
NCT01881646 -
Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery
|
Phase 4 | |
| Recruiting |
NCT05888961 -
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
|
N/A | |
| Completed |
NCT01983384 -
Anesthetic Depth and Postoperative Delirium Trial - 2
|
N/A | |
| Completed |
NCT02575482 -
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00937846 -
Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
|
Phase 1 | |
| Completed |
NCT01772095 -
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE
|
N/A | |
| Completed |
NCT06078332 -
Remote Cognitive Multidomain Assessment in People With Cognitive Disorders
|